• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics

Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics

9780323793537
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
646.38 zł
549.42 zł Save 96.96 zł Tax included
Lowest price within 30 days before promotion: 549.42 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

In this issue of Thoracic Surgery Clinics, guest editor Farid Shamji brings considerable expertise to the topic of Lung Cancer.

Product Details
Elsevier
91726
9780323793537
9780323793537

Data sheet

Publication date
2021
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
500
  • How to Design and Foster Thoracic Oncology Multidisciplinary Cancer Conferences
    Guiding Principles in the Management of Synchronous and Metachronous Primary Non-Small Cell Lung Cancer
    When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
    Management of Air Leaks and Residual Spaces Following Lung Resection
    Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
    Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
    Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
    Constants and Currents in the Education and Training of General Thoracic Surgeons
    Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
    Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
    Embolotherapy in Bronchial Hemorrhage
    Ethics for Thoracic Surgeons in the Management of Lung Cancer
    Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
    Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
    Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?
Comments (0)